Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances.
作者信息
Di Trana Annagiulia, Carlier Jeremy, Berretta Paolo, Zaami Simona, Ricci Giovanna
机构信息
Unit of Forensic Toxicology, Section of Legal Medicine, Department of Excellence of Biomedical Sciences and Public Health, Polytechnic University of Marche, Ancona, Italy.
Unit of Forensic Toxicology, Section of Legal Medicine, Department of Anatomical, Histological, Forensic, and Orthopedic Sciences, Sapienza University of Rome, Rome, Italy.
出版信息
Front Psychiatry. 2020 Oct 23;11:584462. doi: 10.3389/fpsyt.2020.584462. eCollection 2020.
Abstract
摘要
相似文献
1
Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances.
Front Psychiatry. 2020 Oct 23;11:584462. doi: 10.3389/fpsyt.2020.584462. eCollection 2020.
2
The consequences of drug misuse on post-marketing surveillance.
Expert Rev Clin Pharmacol. 2016 Jul;9(7):867-71. doi: 10.1080/17512433.2016.1178571. Epub 2016 Apr 25.
3
What products are considered psychoactive under New Zealand's legal market for new psychoactive substances (NPS, 'legal highs')? Implications for law enforcement and penalties.
Drug Test Anal. 2016 Aug;8(8):768-78. doi: 10.1002/dta.1943. Epub 2016 Feb 9.
4
Economic consequences of legal and illegal drugs: The case of social costs in Belgium.
Int J Drug Policy. 2017 Jun;44:50-57. doi: 10.1016/j.drugpo.2017.03.005. Epub 2017 Apr 23.
5
Prevalence of consumption of psychoactive substances amongst dockers.
Int Marit Health. 2018;69(2):118-125. doi: 10.5603/IMH.2018.0017.
6
Methodological Considerations in Social Cost Studies of Addictive Substances: A Systematic Literature Review.
Front Public Health. 2017 Jan 18;4:295. doi: 10.3389/fpubh.2016.00295. eCollection 2016.
7
Updated North Cyprus response status for COVID-19 in comparison with similar country sizes. Highlights on the importance of population per square meter.
Multidiscip Respir Med. 2020 Sep 22;15(1):699. doi: 10.4081/mrm.2020.699. eCollection 2020 Jan 28.
8
Legal high industry business and lobbying strategies under a legal market for new psychoactive substances (NPS, 'legal highs') in New Zealand.
Int J Drug Policy. 2016 Nov;37:90-97. doi: 10.1016/j.drugpo.2016.08.011. Epub 2016 Sep 15.
9
Current challenges and problems in the field of new psychoactive substances in Germany from a law enforcement perspective.
Drug Test Anal. 2014 Jul-Aug;6(7-8):876-8. doi: 10.1002/dta.1604. Epub 2014 Jan 10.
10
Evaluation of the exposure risk of SARS-CoV-2 in different hospital environment.
Sustain Cities Soc. 2020 Oct;61:102413. doi: 10.1016/j.scs.2020.102413. Epub 2020 Jul 22.
引用本文的文献
1
Kazakhstani Drivers and Substance Abuse During COVID-19: A Study of Patterns and Disaster Readiness.
Healthcare (Basel). 2025 Mar 28;13(7):756. doi: 10.3390/healthcare13070756.
2
A cohort-based assessment of drug use trends during the COVID-19 pandemic: relationship with mood and sociodemographic factors in Brazil.
Front Psychiatry. 2025 Jan 30;16:1514365. doi: 10.3389/fpsyt.2025.1514365. eCollection 2025.
3
Analysis of crude wastewater from two treatment plants in South Wales for 35 new psychoactive substances and cocaine, and cannabis.
Sci Rep. 2024 Aug 29;14(1):20129. doi: 10.1038/s41598-024-70378-7.
4
The Adverse Effects and Nonmedical Use of Methylphenidate Before and After the Outbreak of COVID-19: Machine Learning Analysis.
J Med Internet Res. 2023 Aug 16;25:e45146. doi: 10.2196/45146.
5
Synthetic Cathinones and Neurotoxicity Risks: A Systematic Review.
Int J Mol Sci. 2023 Mar 25;24(7):6230. doi: 10.3390/ijms24076230.
6
Changes in prescription drug abuse during the COVID-19 pandemic evidenced in the Catalan pharmacies.
Front Public Health. 2023 Feb 14;11:1116337. doi: 10.3389/fpubh.2023.1116337. eCollection 2023.
7
New Psychoactive Substances Intoxications and Fatalities during the COVID-19 Epidemic.
Biology (Basel). 2023 Feb 8;12(2):273. doi: 10.3390/biology12020273.
8
Coffee Consumption during the COVID Pandemic in a Portuguese Sample: An Online Exploratory Study.
Foods. 2023 Jan 16;12(2):421. doi: 10.3390/foods12020421.
9
Molecular Insights and Clinical Outcomes of Drugs of Abuse Adulteration: New Trends and New Psychoactive Substances.
Int J Mol Sci. 2022 Nov 23;23(23):14619. doi: 10.3390/ijms232314619.
10
Impact of COVID-19 lockdown on substance availability, accessibility, pricing, and quality: A multicenter study from India.
Indian J Psychiatry. 2022 Sep-Oct;64(5):466-472. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_864_21. Epub 2022 Oct 12.
本文引用的文献
1
COVID-19: The Hidden Impact on Mental Health and Drug Addiction.
Front Psychiatry. 2020 Jul 29;11:767. doi: 10.3389/fpsyt.2020.00767. eCollection 2020.
2
New Trends of Substance Abuse During COVID-19 Pandemic: An International Perspective.
Front Psychiatry. 2020 Jul 16;11:700. doi: 10.3389/fpsyt.2020.00700. eCollection 2020.
3
New psychoactive substances on dark web markets: From deal solicitation to forensic analysis of purchased substances.
Drug Test Anal. 2021 Jan;13(1):156-168. doi: 10.1002/dta.2901. Epub 2020 Aug 7.
4
Addictovigilance contribution during COVID-19 epidemic and lockdown in France.
Therapie. 2020 Jul-Aug;75(4):343-354. doi: 10.1016/j.therap.2020.06.006. Epub 2020 Jun 23.
5
Addiction psychiatry and COVID-19: impact on patients and service provision.
Ir J Psychol Med. 2020 Sep;37(3):164-168. doi: 10.1017/ipm.2020.47. Epub 2020 May 21.
6
SARS-CoV-2 identification in lungs, heart and kidney specimens by transmission and scanning electron microscopy.
Eur Rev Med Pharmacol Sci. 2020 May;24(9):5186-5188. doi: 10.26355/eurrev_202005_21217.
7
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.
Int J Antimicrob Agents. 2020 Mar;55(3):105924. doi: 10.1016/j.ijantimicag.2020.105924. Epub 2020 Feb 17.
8
Psychoactive drugs and driving.
Aust Prescr. 2019 Dec;42(6):182-185. doi: 10.18773/austprescr.2019.070. Epub 2019 Dec 2.
9
New psychoactive substances: concerted efforts and common legislative answers for stemming a growing health hazard.
Eur Rev Med Pharmacol Sci. 2019 Nov;23(22):9681-9690. doi: 10.26355/eurrev_201911_19529.
10
Assessing the 2004-2018 Fentanyl Misusing Issues Reported to an International Range of Adverse Reporting Systems.
Front Pharmacol. 2019 Feb 1;10:46. doi: 10.3389/fphar.2019.00046. eCollection 2019.
Zotero 插件